Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
ArticleAçık Erişim
Anahtar Kelimeler
Adjuvant chemotherapyColon cancerctDNAOlder patientsAgedBiomarkers, TumorChemotherapy, AdjuvantCirculating Tumor DNAColonic NeoplasmsHumansNeoplasm Recurrence, LocalNeoplasm Stagingfluorouraciloxaliplatinpembrolizumabtumor markerArticlecancer chemotherapycancer recurrencecancer stagingcognitioncomorbiditydecision makingdisease free survivalECOG Performance Statusfollow upgeriatric patienthumanKarnofsky Performance Statusmicrosatellite instability
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12373Resmi atıflarda kullanılan kalıcı adresTam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Akagündüz, Baran | |
| dc.contributor.author | Guven, Deniz Can | |
| dc.contributor.author | Ozer, Muhammet | |
| dc.contributor.author | Okten, Ilker Nihat | |
| dc.contributor.author | Atag, Elif | |
| dc.contributor.author | Unek, İlkay Tugba | |
| dc.contributor.author | Tatli, Ali Murat | |
| dc.contributor.author | Karaoglu, Aziz | |
| dc.date.accessioned | 2026-10-18T20:27:16.937132198Z | |
| dc.date.available | 2026-10-18T20:27:16.937132198Z | |
| dc.date.issued | 2023 | |
| dc.identifier.doi | 10.1016/j.jgo.2022.08.016 | |
| dc.identifier.issn | 1879-4068 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 36038467 | |
| dc.identifier.scopus | 2-s2.0-85136699385 | |
| dc.identifier.startpage | 101367 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12373 | |
| dc.identifier.volume | 14 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ltd | |
| dc.relation.ispartof | Journal of Geriatric Oncology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Adjuvant chemotherapy | |
| dc.subject | Colon cancer | |
| dc.subject | ctDNA | |
| dc.subject | Older patients | |
| dc.subject | Aged | |
| dc.subject | Biomarkers, Tumor | |
| dc.subject | Chemotherapy, Adjuvant | |
| dc.subject | Circulating Tumor DNA | |
| dc.subject | Colonic Neoplasms | |
| dc.subject | Humans | |
| dc.subject | Neoplasm Recurrence, Local | |
| dc.subject | Neoplasm Staging | |
| dc.subject | fluorouracil | |
| dc.subject | oxaliplatin | |
| dc.subject | pembrolizumab | |
| dc.subject | tumor marker | |
| dc.subject | Article | |
| dc.subject | cancer chemotherapy | |
| dc.subject | cancer recurrence | |
| dc.subject | cancer staging | |
| dc.subject | cognition | |
| dc.subject | comorbidity | |
| dc.subject | decision making | |
| dc.subject | disease free survival | |
| dc.subject | ECOG Performance Status | |
| dc.subject | follow up | |
| dc.subject | geriatric patient | |
| dc.subject | human | |
| dc.subject | Karnofsky Performance Status | |
| dc.subject | microsatellite instability | |
| dc.title | Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 1 | |
| rdl.department | Department of Medical Oncology, Erzincan Binali Yıldrıım University Medical School, Erzincan, Turkey. Electronic address: drbaran04@hotmail.com. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | PUBMED |
